News April 25, 2022 RayzeBio Appoints Angie You, Ph.D., to its Board of DirectorsRead more ⟶ January 24, 2022 RayzeBio Expands Leadership Team with Arvind Kush, as Chief Financial Officer; and Aubrey Haddach, J.D., as General CounselRead more ⟶ January 6, 2022 RayzeBio to Present at J.P. Morgan Healthcare Virtual Conference on Tuesday, January 11, 2022Read more ⟶ October 12, 2021 RayzeBio Appoints Mary Tagliaferri, M.D. to its Board of Directors and Expands Leadership Team with Rozalyn Littler as VP of Regulatory and QualityRead more ⟶ August 31, 2021 RayzeBio Expands Leadership Team with Susan Moran, M.D., as Chief Medical Officer; Kimberly Ma, M.S., as SVP of Clinical Operations; and Nicholas Smith, Ph.D., as SVP of Chemistry InnovationRead more ⟶ July 12, 2021 48Hour Discovery and RayzeBio Announce strategic Research Collaboration to Discover & Develop Novel Peptide-Based RadiopharmaceuticalsRead more ⟶ June 28, 2021 Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based RadiopharmaceuticalsRead more ⟶ June 15, 2021 RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for CancerRead more ⟶ April 21, 2021 RayzeBio Appoints Yi Larson to Its Board of Directors and Expands Team with Key Leadership HiresRead more ⟶
